Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

PHC and Arysta LifeScience Terminate Agreement

30 Nov 2015 07:00

RNS Number : 9951G
Plant Health Care PLC
30 November 2015
 

Plant Health Care and Arysta LifeScience Announce Termination of Combination Products Agreement

 

Raleigh / Cary, NC, November 30, 2015. Plant Health Care, Inc., a leading supplier of novel patent-protected biological products, and Arysta LifeScience, a leading crop protection and life science company, have mutually agreed to terminate the product development and license agreement enabling Arysta LifeScience to sell combination products containing Plant Health Care's Harpin

𝜶β protein technology combined with Arysta LifeScience's crop protection products in the U.S. row crop market.

 

Challenging conditions in agricultural markets driven by weak crop prices, especially in row crops, coupled with focus on the organizational merger of Chemtura AgroSolutions, Agriphar and Arysta LifeScience contributed to an unsuccessful launch of the first combination product under the agreement.

 

Plant Health Care will now have enhanced flexibility to deploy their resources toward opportunities in high-value specialty crops while accessing row crop markets in the U.S. with Harpin 𝜶β as both a straight product and in combination with mixture partners. Arysta LifeScience, now owned by Platform Specialty Products, will continue to offer a range of crop protection products including fungicides for both seed treatment and foliar application in row crop markets.

 

The companies continue to work together to bring Plant Health Care's technology to market in Brazil through foliar applications on sugarcane and to seek other opportunities for global collaboration.

 

About Plant Health Care: Plant Health Care is a leading provider of novel patent-protected biological products to the global agriculture markets. In this way, Plant Health Care is capitalising on long-term trends toward natural systems and biological products for plant care and soil and water management. The Company's ordinary shares have been quoted on the AIM market of the London Stock Exchange since July 2004 (ticker symbol: PHC). More information on the company is available at www.planthealthcare.com

 

About Arysta LifeScience Limited

Arysta LifeScience, now owned by Platform Specialty Products, is a leading crop protection and life science company with 2014 revenues of US $2.2 billion. An entrepreneurial provider of crop protection and life science products in more than 125 countries worldwide, Arysta LifeScience specializes in marketing and distribution of respected crop protection brands and life science products that meet the needs of its global partners. More information on the company is available at www.arystalifescience.com.

 

For further information, please contact:

 

Plant Health Care plc

Jeff Tweedy, Head of Commercial Operations Tel: +1 (919) 926 1600

 

Arysta LifeScience

Linda Frerichs, Global & North America Communications Tel: +1 (919) 678-4948

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRFESFUIFISEDF
Date   Source Headline
21st Aug 20247:00 amRNSCancellation - Plant Health Care plc
20th Aug 202410:59 amRNSForm 8.5 (EPT/NON-RI)
20th Aug 202410:17 amRNSScheme of Arrangement becomes Effective
20th Aug 20247:30 amRNSSuspension - Plant Health Care plc
16th Aug 202410:14 amRNSExercise of Options & Rule 2.9 Announcement
16th Aug 20249:13 amRNSForm 8.5 (EPT/NON-RI)
15th Aug 202412:44 pmRNSCourt sanction of the Scheme of Arrangement
7th Aug 20246:02 pmRNSForm 8.3 - Plant Health Care Plc
7th Aug 20242:01 pmRNSForm 8.3 - Plant Health Care plc
7th Aug 20249:08 amRNSForm 8.3 - Plant Health Care PLC
6th Aug 20243:08 pmRNSResult of Court Meeting and General Meeting
6th Aug 20241:54 pmRNSForm 8.3 - Plant Health Care plc
6th Aug 202412:45 pmRNSHolding(s) in Company
5th Aug 20242:01 pmRNSForm 8.3 - Plant Health Care plc
5th Aug 20241:39 pmRNSResults of Court Meeting and General Meeting
2nd Aug 20242:00 pmRNSForm 8.3 - Plant Health Care plc
2nd Aug 20248:25 amRNSForm 8.3 - Plant Health Care PLC
1st Aug 20249:33 amRNSForm 8.3 - Plant Health Care PLC
1st Aug 20249:03 amRNSForm 8.5 (EPT/NON-RI)
1st Aug 20248:46 amRNSForm 8.3 - PLANT HEALTH CARE PLC
31st Jul 202411:21 amRNSForm 8.3 - Plant Health Care Plc
29th Jul 20241:09 pmRNSHolding(s) in Company
29th Jul 20248:51 amRNSForm 8.3 - PLANT HEALTH CARE PLC
24th Jul 20247:00 amRNSExpanded Recommendations for OBRONA
23rd Jul 20249:20 amRNSForm 8.5 (EPT/NON-RI) - Plant Health Care PLC
22nd Jul 202411:17 amRNSForm 8.5 (EPT/NON-RI)
19th Jul 20242:36 pmRNSForm 8.5 (EPT/NON-RI)
19th Jul 20242:10 pmRNSForm 8.3 - Plant Health Care plc
18th Jul 20249:05 amRNSForm 8.5 (EPT/NON-RI)
17th Jul 20249:03 amRNSForm 8.5 (EPT/NON-RI) - Plant Health Care PLC
16th Jul 20242:48 pmRNSForm 8.3 - Plant Health Care plc
16th Jul 202410:01 amRNSForm 8.5 (EPT/NON-RI)
15th Jul 202411:25 amRNSForm 8.5 (EPT/NON-RI)
15th Jul 202410:58 amRNSForm 8.3 - Plant Health Care Plc
12th Jul 20241:36 pmRNSForm 8.3 - Plant Health Care PLC
11th Jul 20242:28 pmRNSForm 8.3 - Plant Health Care plc
10th Jul 20243:44 pmRNSForm 8.3 - Plant Health Care plc
10th Jul 20242:58 pmRNSPublication and posting of the Scheme Document
10th Jul 20242:03 pmRNSForm 8.3 - Plant Health Care plc
10th Jul 202410:36 amRNSForm 8 (OPD) - Plant Health Care
9th Jul 20241:57 pmRNSForm 8.3 - Plant Health Care plc
9th Jul 202410:19 amRNSForm 8.3 - Plant Health Care plc - Ospraie Ag
8th Jul 20242:00 pmRNSForm 8.3 - Plant Health Care plc
8th Jul 20241:56 pmRNSForm 8.3 - Plant Health Care Plc
4th Jul 20241:40 pmPRNForm 8.3 - Plant Health Care plc
4th Jul 202411:09 amRNSForm 8.3 - Plant Health Care PLC - Amendment
4th Jul 20248:34 amRNSForm 8.3 - Plant Health Care PLC
3rd Jul 20241:57 pmRNSForm 8.3 - Plant Health Care plc
3rd Jul 20249:26 amRNSForm 8.3 - Plant Health Care plc
3rd Jul 20249:07 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.